These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 59568)

  • 1. [Therapy of dysmenorrhea].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
    [No Abstract]   [Full Text] [Related]  

  • 2. [Intrahepatic cholestasis following ovosiston].
    Kraatz G; Linke A
    Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary dysmenorrhea: combination vs sequential therapy.
    Buttram VC; Kaufman RH
    Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
    Roland M; Clyman M; Decker A; Ober WB
    Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gestranol in treatment of excessive postpartum breast intumescence].
    Ostrzeński A
    Pol Tyg Lek; 1974 Mar; 29(12):489-90. PubMed ID: 4132234
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of seborrheic conditions of the female scalp using modern combined peroral estrogen-gestagen preparations].
    Spirov G; Berova N; Vasilev D
    Vestn Dermatol Venerol; 1973 Jul; 47(7):30-3. PubMed ID: 4127925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advantage of the use of an estroprogestational drug: 3 mg of chlormadinone acetate + 100 mcg of mestranol in endocrine gynecology].
    Bernard I
    Bord Med; 1970; 3(7):1954-60. PubMed ID: 4195405
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind trial of a sequential oral contraceptive (Sequens) in the treatment of dysmenorrhoea.
    Matthews AE; Clarke JE
    J Obstet Gynaecol Br Commonw; 1968 Nov; 75(11):1117-22. PubMed ID: 4177921
    [No Abstract]   [Full Text] [Related]  

  • 9. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
    Müller R; Kempf HJ; Eckert L
    Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation].
    Spirov G; Vetsova N
    Vestn Dermatol Venerol; 1975 Feb; (2):57-8. PubMed ID: 50675
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of sequential mestranol-chlormadinone on sebum production.
    Pochi PE; Strauss JS
    Arch Dermatol; 1967 Jan; 95(1):47-9. PubMed ID: 4163188
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
    Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
    Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary infarction associated with ovulation inhibitors].
    Dejaco RM; Hartl O; Pürgyi P
    Wien Med Wochenschr; 1972 Nov; 122(43):630-2. PubMed ID: 4120546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of mestranol and chlormadinone acetate on HGH secretion in Turner's syndrome].
    Rudolf K; Kunkel S; Woltanski KP
    Zentralbl Gynakol; 1985; 107(23):1454-9. PubMed ID: 2420102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative cytological and histological studies following the use of an ovulation inhibiting estrogen-gestagen combination (Ovositon)].
    Krause W; Böhm W; Müller W
    Gynaecologia; 1968; 166(5):432-45. PubMed ID: 4179218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
    Ebeling K; Kühndel K; Rothe K; Canzler E
    Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of mestranol and chlormadinone acetate on basal and TRH-stimulated PRL secretion in Turner's syndrome].
    Rudolf K; Kunkel S; Pelz L
    Zentralbl Gynakol; 1985; 107(23):1446-53. PubMed ID: 2420101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personal experience in the management of the post-menopausal patient using sequential 11 plus 10 therapy (mestranol 30 mcg. and chlormadinone 1 mlg. plus mestranol 80 mcg)].
    González Gutiérrez JT
    Ginecol Obstet Mex; 1969 May; 24(151):531-7. PubMed ID: 4186794
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with a gestagen-estrogen preparation (AK 103=Aconcen)].
    Kalchauer B
    Ther Ggw; 1966 Jul; 105(7):938-9. PubMed ID: 4162578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.